ARID3A, member of AT-rich interaction domain (ARID) family, is a transcriptional factor that has been already implicated in HCC, up-regulated in tumor samples, partly due to DNA demethylation at its gene locus, and related to a poor outcome [46,47,48,49]. This evidence concerns the gene ARID3A and neoplasm.